Live Breaking News & Updates on David Novitski

Stay updated with breaking news from David novitski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development


Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development
News provided by
Share this article
Financialnewsmedia.com News Commentary
PALM BEACH, Fla., June 15, 2021 /PRNewswire/ The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising medicines can get to the people who need them the most, they must pass through the extensive drug development pipeline, where IP & Patents are crucial. It seems that a week doesn t go by without a psychedelic company saying it has filed for a new patent. An informative article on Microdose explains the reasons why psychedelic companies are pursuing these patents. First, the plants that the medicines are based on can t be patented. Products in nature belong to the public and thus can t be patented. Microdose wrote, One company cannot claim it as intellectual property to exclusively prof ....

United States , United Kingdom , British Columbia , Matthias Liechti , David Novitski , Paul Pedersen , British American Tobacco , Fn Media Group , Cardiol Therapeutics Inc , Trademark Office , Nextleaf Solutions , Specialty Molecules Division , Health Numinus , Yougov Plc , Nextleaf Solutions Ltd , Optimi Health Corp , Numinus Wellness Inc , Company Specialty Molecule Division , Nextleaf Launches Specialty Molecules Division , Exchange Commission , Field Trip Health Ltd , University Of Calgary , Speciality Molecules Division , Securities Exchange , University Hospital Basel Liechti Lab , Health Canada ,